Balzan M V
Department of Medicine, St Luke's Hospital, Malta.
Postgrad Med J. 1998 Feb;74(868):72-6. doi: 10.1136/pgmj.74.868.72.
The neuroleptic malignant syndrome is a rare, potentially fatal, adverse reaction to neuroleptic drugs characterised by severe rigidity, high temperature and autonomic dysfunction. In the light of the hypothesized pathophysiology of this condition, a rational approach to the management of patients presenting with temperature and rigidity is provided. The aims of this approach are three-fold: to reduce the incidence of the condition, to be able to recognise it early so as to treat before life-threatening complications arise, and to be able to recognise early those conditions which mimic neuroleptic malignant syndrome, so as not to delay their specific treatment.
抗精神病药物恶性综合征是一种罕见的、潜在致命的抗精神病药物不良反应,其特征为严重的强直、高热及自主神经功能障碍。根据该病症的假定病理生理学,本文提供了一种针对出现高热和强直症状患者的合理管理方法。该方法的目标有三个方面:降低该病症的发生率,能够早期识别以便在危及生命的并发症出现之前进行治疗,以及能够早期识别那些酷似抗精神病药物恶性综合征的病症,以免延误其特异性治疗。